Serotype chimeric human adenoviruses for cancer gene therapy. - Wikidata - wikimedia - TriplyDB

Serotype chimeric human adenoviruses for cancer gene therapy.

Serotype chimeric human adenoviruses for cancer gene therapy.

http://www.wikidata.org/entity/Q37945193

about

Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs Current status of gene therapy for brain tumors.Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers.Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro.Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer

P2860

Q26782083-FC354130-E779-4A5F-8BE8-47D99BB200A9 Q34318157-6A7C73D3-11A0-41B1-B676-5D9DE18F572E Q37132233-F59E0889-E39D-4C92-A977-D1DD30C3F922 Q37437450-063A36DD-C435-4E68-9792-AEC8C56A4D72 Q38033591-CCDEFC3C-6D52-42AD-8385-DAF3C5F38816 Q39020219-59E6A95A-7C37-4487-9680-A8E6FD8D61F9 Q39107708-1CEA7E9B-8B77-4815-B665-84E2C116C901 Q40041705-FEEBA75B-D58A-4DCE-8CA2-B91799AB0ED7 Q58753310-16E994BF-6883-4045-BE20-2B0C674DCCD9

P2860

Serotype chimeric human adenoviruses for cancer gene therapy.

http://www.wikidata.org/entity/Q37945193

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Serotype chimeric human adenoviruses for cancer gene therapy.

@en

Serotype chimeric human adenoviruses for cancer gene therapy.

@nl

type

label

Serotype chimeric human adenoviruses for cancer gene therapy.

@en

Serotype chimeric human adenoviruses for cancer gene therapy.

@nl

prefLabel

Serotype chimeric human adenoviruses for cancer gene therapy.

@en

Serotype chimeric human adenoviruses for cancer gene therapy.

@nl

P1433

Q37945193-295A7DAF-8ADA-4A41-AA6A-343307A1437C

P1476

Q37945193-F03D8225-C4B7-47F8-A0F9-8E8FE5FE06CF

P2093

Q37945193-63D0BFAC-5E60-4234-B60B-98E8A4055F72

P2860

Q37945193-00E4326C-8434-4210-8BB8-8031E99B670C

Q37945193-028DEACE-6FD1-4C40-9A3B-EE5F71518644

Q37945193-0494E6B1-739A-4613-AE86-2E395B997AEE

Q37945193-0B8E18F4-F7BA-4C8D-8BAC-E69005964DD9

Q37945193-104A36B3-2B0C-4349-9CA4-D7BC9747F66D

Q37945193-1134FA1B-597F-48B3-9569-06F35A06DC7C

Q37945193-1249E986-5E0E-41A7-BAA9-625F4D8A613E

Q37945193-13EFE70D-7850-49FD-AE92-B861FAD250F4

Q37945193-15B415A5-AD47-43D6-8830-D3F5A622FE88

Q37945193-166191D4-937C-4162-89DA-BD2B5B9D794F

P304

Q37945193-D8F6948A-CE6A-4EF4-A3C7-22B191A56530

P31

Q37945193-BA49744C-593E-4675-AE3B-7EE4372EB9CC

P356

Q37945193-F249AD15-DB1E-4EE5-A044-BE91026308E4

P433

Q37945193-2B67C23F-9649-4FCF-B7B0-8BCB7416FB02

P478

Q37945193-02503552-597F-41C0-AD0F-D4181BCECB36

P50

Q37945193-ACF51169-32B2-4474-8A8A-BAEEDA7C9F39

P577

Q37945193-BC3DFCCA-F145-4DA4-8955-928E12AB2DFB

P5875

Q37945193-E97A43FA-F14A-4698-A00B-43A26B36BB87

P698

Q37945193-CDBC6A92-72B0-47C8-B294-2835EF0078ED

P921

Q37945193-2CAE3C33-7C69-4203-BECC-C5A2ADE03F04

Q37945193-56A1E24B-2126-4F36-A620-FC3A108CD834

P932

Q37945193-5DCCD85C-5053-44EB-9A72-B3A5477296C3

P356

P1433

P1476

Serotype chimeric human adenoviruses for cancer gene therapy.

@en

P2093

Tuuli Ranki

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

Global cancer statistics, 2002

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Tissue-specific promoters active in CD44+CD24-/low breast cancer cells

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

Improved adenovirus vectors for infection of cardiovascular tissues

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.

Development of renal-targeted vectors through combined in vivo phage display and capsid engineering of adenoviral fibers from serotype 19p.

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.

P304

2196-2212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V2102196

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Akseli Hemminki

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51711947

http://www.w3.org/2001/XMLSchema#string

P698

21994616

http://www.w3.org/2001/XMLSchema#string

P921

P932

3185575

http://www.w3.org/2001/XMLSchema#string